RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Scott Kuwada to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Scott Kuwada has written about Clinical Trials as Topic.
Scott Kuwada
Connection Strength
0.350
Clinical Trials as Topic
  1. Kuwada SK. Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. Curr Opin Mol Ther. 2007 Feb; 9(1):92-8.
    View in: PubMed
    Score: 0.261
  2. Kuwada SK, Burt R. A rationale for mTOR inhibitors as chemoprevention agents in Peutz-Jeghers syndrome. Fam Cancer. 2011 Sep; 10(3):469-72.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support